The spasticity landscape offers opportunities with over 10 companies and 12 pipeline drugs in development. Key prospects lie in novel therapies like Motric Bio's MTR-601 and Ipsen's IPN10200. Focused ...
Sativex, a cannabis-based spray for MS spasticity, was bought by CNX Therapeutics. It's used as an add-on therapy in Europe ...
NEWARK, Del, May 09, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, the valuation for the global spasticity treatment market was around US$ 12.2 Billion in 2022 and ...
Using cryotherapy guided by non-invasive ultrasound, Victoria doctors are helping patients with spasticity to unlock their ...
Q: My husband is recovering from a stroke, which he experienced six months ago. His entire right arm is stiff, and his hand is held in a clenched fist. This makes it hard for him to do daily tasks, ...
Sativex is indicated for symptom improvement in adult patients with moderate to severe spasticity. Inflexion portfolio company CNX Therapeutics has acquired the global Sativex business from Jazz ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback